Prolonged seizures and status epilepticus are a common acute neurological presentation in
pediatric practice. As a result, there is a need for effective and safe medications that can be …

A Prolonged convulsive seizure is the most common neurological medical emergency with
poor outcome. An ideal anticonvulsant should be easy-to-use, effective, and safe, and it …

Oromucosal midazolam (Buccolam™) is a benzodiazepine approved for the treatment of
pediatric patients with acute, prolonged, convulsive seizures. This article reviews the …

Midazolam is a relatively new anticonvulsive agent in the benzodiazepine group. It has a
short onset of duration and is practical for use, providing several alternatives such as …

Oromucosal midazolam (Buccolam™), a benzodiazepine, is approved in the EU for the
treatment of paediatric patients (aged 3 months to< 18 years) with acute, prolonged …

Aim Buccal midazolam has emerged as an effective alternative to rectal diazepam in the
management of paediatric status epilepticus. This study aimed to identify carers' views on …

In this study, the authors aimed to evaluate buccal midazolam as a practical and safe
alternative medication for children who suffer from seizures in the emergency setting and in …

Acute seizure and status epilepticus constitute major medical emergencies in children. Four
to six percent of children will have at least one seizure in the first 16 years of life. Status …

Objective The purpose of the present study is to compare efficacy and safety of buccal
midazolam with intravenous diazepam in control of seizures in Iranian children. Methods …

Aim This study aims to explore carer perceptions of training in out‐of‐hospital use of buccal
midazolam for emergency management of seizures. Methods A random sample of 100 …